4-142124619-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001101669.3(INPP4B):c.1862C>T(p.Thr621Met) variant causes a missense change. The variant allele was found at a frequency of 0.000256 in 1,613,432 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001101669.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000479 AC: 120AN: 250724Hom.: 0 AF XY: 0.000413 AC XY: 56AN XY: 135474
GnomAD4 exome AF: 0.000255 AC: 373AN: 1461206Hom.: 1 Cov.: 31 AF XY: 0.000245 AC XY: 178AN XY: 726890
GnomAD4 genome AF: 0.000263 AC: 40AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74398
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1862C>T (p.T621M) alteration is located in exon 20 (coding exon 16) of the INPP4B gene. This alteration results from a C to T substitution at nucleotide position 1862, causing the threonine (T) at amino acid position 621 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at